Oppenheimer Asset Management Inc. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 2.0% in the third quarter, HoldingsChannel.com reports. The fund owned 56,155 shares of the medical equipment provider’s stock after acquiring an additional 1,122 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Intuitive Surgical were worth $27,587,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in the business. Creekmur Asset Management LLC increased its position in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 42 shares during the period. Ridgewood Investments LLC bought a new position in Intuitive Surgical during the second quarter valued at approximately $26,000. Delos Wealth Advisors LLC lifted its position in Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares during the period. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. Finally, LRI Investments LLC bought a new position in Intuitive Surgical during the first quarter valued at approximately $30,000. 83.64% of the stock is owned by institutional investors.
Insider Transactions at Intuitive Surgical
In other news, insider Jamie Samath sold 22,903 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the sale, the insider now owns 8,757 shares in the company, valued at approximately $4,597,425. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares in the company, valued at $402,519.88. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares of the company’s stock, valued at $4,597,425. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 91,178 shares of company stock worth $45,897,071. 0.80% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on Intuitive Surgical
Intuitive Surgical Stock Performance
ISRG stock traded down $0.53 during trading on Wednesday, hitting $536.54. 101,357 shares of the company’s stock traded hands, compared to its average volume of 1,453,387. Intuitive Surgical, Inc. has a 52 week low of $287.98 and a 52 week high of $542.59. The business has a fifty day simple moving average of $495.85 and a 200 day simple moving average of $455.08. The stock has a market capitalization of $191.10 billion, a price-to-earnings ratio of 86.35, a P/E/G ratio of 5.27 and a beta of 1.39.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
- Five stocks we like better than Intuitive Surgical
- Short Selling: How to Short a Stock
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- How to Invest in the Best Canadian Stocks
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
- How to Choose Top Rated Stocks
- Is Palantir’s AI Edge Enough to Justify Its Price?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.